MAGIC New York Draws Increase in Top Retailers and New Exhibiting Brands for Fall Winter Showcase
MAGIC New York welcomed more than a 15% increase in attendance from chain and department store buyers, solidifying MAGIC's integral role as the tentpole destination for women's modern sportswear, young contemporary and trend fashion trade. Attendees previewed and shopped collections from top names alongside emerging designers including Gentle Souls, Elan, Lucy Paris, Betsey Johnson, Mango and Sawary Jeans.
As part of its immersive fashion experience, MAGIC New York hosted a runway show featuring pieces from top exhibiting brands illustrating themes from MMGNET's FW25/26 Women's Young Contemporary Buyer's Guide. The 'Aether' theme emphasized sculptural and modern silhouettes through architectural shapes and structured tailoring. 'Indulge' celebrated bold styling and individualized expression with vibrant colors, layered textures and playful pattern mixing. 'Essentialism' redefined elevated workwear, incorporating luxe fabrics, embellishments and unconventional material pairings. 'Mythos' embraced traditional textile techniques and folk-inspired craftmanship by utilizing earthy tones and sustainable materials. These curated concepts provided buyers with key insights into season's most defining styles and how they will translate into retail.
'This season, MAGIC New York showcased not only the latest collections in women's modern sportswear, young contemporary and trend, but also the industry's evolving priorities of personalized shopping experiences, impactful retail strategies and sustainability resources,' Jordan Rudow, Vice President of MAGIC. 'As an essential global marketplace for collaboration, education and business growth, we continue to deliver the insights and resources needed to navigate today's dynamic retail landscape'
Education sessions were designed to provide strategic insights into the shifting retail landscape. Topics covered 'From Culture to the Selling Floor' presented by Fashion Snoops, unpacking the season's most important cultural signals, must-have key items and merchandising strategies to help retailers refine their product assortments. Additional programs included 'Winning at Retail in 2025" discussing strategies for increasing profitability for boutique owners and specialty stores, as well as the 'Four Marketing Errors That Could Be Stifling Your Boutique's Foot Traffic' exploring common promotional pitfalls in bricks and mortar and how to avoid them.
MAGIC New York continues to collaborate with Hey Social Good, spotlighting resource and cost reduction initiatives and insights throughout the event, offering brands guidance on how to integrate responsible business practices into operations ultimately improving bottom line. The Sustainability Award Program recognized brands taking meaningful steps toward reducing environmental impact, ensuring sustainability remains priority in industry conversations.
With trend driven showcases and a strong mix of established and emerging brands, MAGIC New York offers retailers fresh discoveries, valuable industry insights and meaningful connections influencing the season ahead.
Upcoming 2025 show dates include MAGIC Nashville, April 16-17, MAGIC Las Vegas, August 18-20, MAGIC New York, September 14-16, MAGIC Nashville, trading October 2-3. For more information on how to attend or become an exhibitor, please visit www.magicfashionevents.com
About MAGIC
MAGIC is a high-energy fashion experience and home to the industry's largest selection of trend-driven and young contemporary apparel, footwear, and accessories. Fusing scale with curation to drive commerce, creativity, and connections, MAGIC joins a global audience of retail buyers - from big-box to boutique - with influencers, media, and industry thought leaders. More than just events, MAGIC is a deeply rooted community, and a place brands and retailers call home. For more information, please visit www.magicfashionevents.com.
About Informa Markets Fashion
Informa Markets Fashion, branded as MMGNET Group, is fashion's newest B2B ecosystem and the go-to industry resource, where industry professionals go to source the inspiration, connections, and opportunities they need to build business, network, and responsibly steward fashion forward. Through its extensive global reach, decades of unwavering industry expertise, world-class content programs, and a comprehensive portfolio of trade and industry event brands - including MAGIC, PROJECT, COTERIE, and SOURCING at MAGIC - MMGNET Group delivers year-round opportunities to learn, grow, connect, and discover. MMGNET Group is a subsidiary of Informa Markets (LON:INF). To learn more about MMGNET and the MMGNET Group portfolio of brands, please visit www.mmgnetgroup.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
12 hours ago
- TechCrunch
Not everyone is thrilled with Threads' DMs
Earlier this week, Instagram Threads launched what the company said was its most-requested feature to date: direct messages, also known as DMs. However, the company is now facing a bit of a user backlash over the addition, as users, primarily women, are arguing that there should be a way to opt out of DMs entirely, citing harassment concerns. Although DMs are a part of other social networks similar to Threads, including X, Bluesky, Mastodon, and others, some Threads users appreciated that they were not an option previously. 'I don't want to receive DM's. How do I shut this thing off? I ask on behalf of all women,' one Threads user posted on the platform. 'Great. More ways for women to get harassed online,' said another. 'Congrats on adding a feature only stalkers were interested in,' chimed in a third. Many others replied to the announcement about DMs, which was shared on Threads by Instagram head Adam Mosseri. Across dozens of posts, some of these users wrote they didn't want DMs or claimed that 'nobody asked for this.' One person pointed to a poll with thousands of votes where Threads users indicated they overwhelmingly would have preferred not to have a DM feature. Several asked if there was a way to turn the feature off. (There is not.) Techcrunch event Save $450 on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $450 on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW While harassment is a one concern, others worry about inboxes flooded with bots, spam, and other unwelcome outreach. The way the system is currently designed, you have to follow a user for them to have the option to DM you. If that person bothers you, unfollowing them will revoke their access to your inbox. (For a more nuclear option, you can choose to block the user, which blocks them on Instagram, too.) Arguably, those upset by the feature's addition are more likely to have shared their thoughts online — similar to how consumers tend to post bad reviews of businesses on places like Google Maps and Yelp, but not their positive experiences. Still, those complaining may have a point. As a social media platform grows, adding new features after the culture is already set can cause disruption. Creating a non-public way for users to interact changes how some people want to use Threads. Meanwhile, users' lack of control over the experience, like an opt-out option, leaves them feeling helpless. Meta may have felt that by tying DMs to followers, it was giving users a way to decide who could reach them more privately. But what the company failed to understand is that on a public social network like Threads, users may find themselves following people whose posts and opinions they want to read, but who, as strangers, they'd rather keep their distance from.
Miami Herald
18 hours ago
- Miami Herald
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / July 3, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced positive preclinical data demonstrating that Mira-55, the Company's proprietary non-psychotropic marijuana analog, delivered morphine-comparable pain relief in a validated model of inflammatory pain-without causing local inflammation. Mira-55 is a next-generation analog of marijuana, engineered to selectively activate CB2 cannabinoid receptors, which are associated with anti-inflammatory and analgesic effects. Unlike THC, Mira-55 minimizes activation of CB1 receptors, reducing the risk of euphoria, sedation, and pro-inflammatory side effects. "These results reinforce the value of Mira-55 as a differentiated cannabinoid-based therapy with real clinical potential," said Erez Aminov, Chairman and CEO of MIRA. "We believe the drug's ability to match morphine's pain relief-without the baggage of addiction, sedation, or THC-like effects-makes Mira-55 an ideal candidate for large, underserved inflammatory pain markets. It's another step in building a non-opioid pain franchise that addresses both inflammatory and neuropathic pain." Study Overview and Key Findings Mira-55 was tested using the formalin model, a gold-standard preclinical method for studying inflammatory pain. In this model, formalin is injected into the rat's paw, producing a pain response that mimics human inflammatory pain. Pain sensitivity was assessed using Von Frey Filament testing, which measures tactile pain thresholds, and inflammation was measured by paw edema volume. Key findings: Mira-55 reduced pain sensitivity by approximately threefold, restoring thresholds to near-baseline analgesic effect was equivalent to morphine, the standard opioid comparator in the sedation or inflammatory swelling was observed with Mira-55 treatment. Importantly, following a scientific review, the U.S. Drug Enforcement Administration (DEA) determined that Mira-55 is not classified as a controlled substance. This designation supports the compound's long-term clinical and commercial viability and removes key barriers typically associated with cannabinoid-based drug development. These results build on prior data from a separate inflammatory pain model conducted by a leading U.S. academic research center, where Mira-55 blocked both thermal and mechanical hyperalgesia without increasing inflammation. In contrast, low-dose THC in that model exacerbated inflammation-further validating Mira-55's selective pharmacological profile. "Mira-55 offers the pain-relieving potential of cannabinoids without the liabilities traditionally seen in THC-based drugs," said Dr. Itzchak Angel, Chief Scientific Advisor at MIRA. "Its novel structure and unique profile with CB2 selectivity and non-scheduled DEA status make it a compelling candidate for treating inflammation-driven pain conditions that are poorly managed by today's standards." Strategic Fit Within MIRA's Pain Portfolio Mira-55 complements Ketamir-2, MIRA's clinical-stage NMDA receptor antagonist, which is advancing through Phase 1 development for neuropathic pain. While Ketamir-2 addresses nerve-related pain through central mechanisms, Mira-55 targets inflammatory pain through the endocannabinoid system. Together, they represent two mechanistically distinct, non-opioid approaches to treating chronic pain. "With Mira-55 and Ketamir-2, we now have two highly differentiated drug candidates with the potential to transform how inflammatory and neuropathic conditions are treated," added Aminov. "We're advancing each asset methodically, and we're energized by the momentum we've built across the pipeline." Corporate Update on SKNY Merger MIRA also announced continued progress on its previously disclosed acquisition of SKNY Pharmaceuticals, the developer of SKNY-1, a novel investigational therapy targeting both obesity and nicotine addiction. In recent studies, SKNY-1 demonstrated a 30% reduction in body weight without muscle loss, along with a reversal of nicotine cravings-highlighting its potential as a differentiated treatment in two major markets. The U.S. Securities and Exchange Commission (SEC) has completed its review of the merger proxy with no comments, allowing MIRA to proceed with shareholder approval and the final steps toward completing the transaction. "We are pleased to report that the SEC had no comments on our merger filing, which reflects the quality of our regulatory and business preparation," said Aminov. "This milestone allows us to advance toward shareholder approval with clarity and confidence as we prepare for the next phase of growth." Next Steps MIRA Pharmaceuticals is advancing Mira-55 toward an Investigational New Drug (IND) submission, with ongoing activities supporting future clinical development in inflammatory pain. The Company remains focused on progressing both lead programs-Mira-55 and Ketamir-2-toward their next regulatory and clinical milestones. About MIRA Pharmaceuticals, Pharmaceuticals, Inc. (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company's pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as neuropathic pain, inflammatory pain, obesity, addiction, anxiety, and cognitive decline. Cautionary Note Regarding Forward-Looking StatementsThis press release and the statements of MIRA's management related thereto contain "forward-looking statements," which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as "aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential," "seeks," "will," and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA's current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA's control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA's potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA's programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and the Form 14A filed by MIRA on June 18, 2025, and other SEC filings, which are on file with the SEC at and on MIRA's website at MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. Contact:Helga Moyainfo@ 432-9792 SOURCE: MIRA Pharmaceuticals
Miami Herald
18 hours ago
- Miami Herald
CMG Financial's Courtney Thompson and Susan Walker Named 2025 HousingWire Women of Influence
SAN RAMON, CA / ACCESS Newswire / July 2, 2025 / CMG Financial, one of the nation's top mortgage lenders, is proud to announce that two of its Executive Vice Presidents, Courtney Thompson and Susan Walker, have been named to HousingWire's 2025 Women of Influence list. This prestigious award honors women in housing who are making notable contributions to both their organizations and the industry at large. With their innovative thinking, leadership, and vision for the future, Courtney and Susan exemplify what it means to lead with impact. "This year's honorees include mentors, innovators, and community leaders," wrote Lesley Collins, HousingWire Editor's Choice Awards Program Manager. "Many are paving the way for future generations through mentorship, volunteer initiatives, and by serving on boards that influence key industry practices. Collectively, their efforts are shaping not only their companies but also the communities they serve and the future of housing itself." Courtney Thompson, EVP of Servicing at CMG, has spent the past year tackling one of the biggest challenges in mortgage servicing: building a modern, borrower-first platform from the ground up. Tasked with developing a fully in-house servicing solution, she's led a bold effort to move beyond outdated legacy systems and create something built for today's consumer. Under her leadership, the platform has taken shape as a fully connected ecosystem-one that keeps loan officers involved post-close, gives borrowers access to personalized tools and insights, and reshapes how homeowners interact with their loans. It's not just a tech project-it's a reinvention of the servicing experience, and it's already drawing attention across the industry. Susan Walker, EVP of Corporate Efficiency at CMG, has spent the past year acting as the voice of the loan officer, translating feedback from top performers into meaningful enhancements to CMG's core platforms, CLEAR and Byte. By embedding herself directly with Product and Technology teams, she helped identify workflow inefficiencies and delivered rapid-fire improvements that drove adoption, boosted morale, and aided in bolstering these systems into competitive strengths. Her impact earned her a seat on the Executive Management Team, where she now oversees Post Closing, Vendor Management, and Product. In this new role, she continues to lead with the same hands-on, cross-functional approach, streamlining operations, reducing costs, and identifying upstream efficiency and alignment opportunities. Her results speak volumes: a West Division that topped $3B in volume, over 100 strategic hires, and a culture that now embraces technology more than ever before. Susan's work isn't just about optimizing systems, it's about building a smarter, more resilient CMG. "Courtney and Susan are both exceptional leaders and trusted partners who bring passion, clarity, and a deep sense of responsibility to everything they do," said Paul Akinmade, Chief Strategy Officer at CMG Financial. "They care deeply about their work, their teams, and the future of this company. What stands out is how they bring people together to drive meaningful change, from the first moments of origination all the way through to servicing." CMG congratulates both honorees and thanks HousingWire for recognizing the leadership, excellence, and trailblazing impact of women across housing finance. To read their full Women of Influence profiles, click here. About CMG CMG Mortgage, Inc. NMLS ID# 1820 ( ) is a well-capitalized mortgage lender founded in 1993. Founder and CEO, Christopher M. George, was Chairman of the Mortgage Bankers Association in 2019. CMG makes its products and services available to the market through three distinct origination channels including retail lending, wholesale lending, and correspondent lending. CMG currently operates in all states, including the District of Columbia, and holds approvals with FNMA, FHLMC, and GNMA. CMG is widely known throughout the mortgage banking and housing markets for responsible lending practices, industry and consumer advocacy, product innovation, and operational efficiency. About HousingWire HousingWire is the most influential source of news and information for the U.S. mortgage and housing markets, boasting a readership that spans lending, servicing, investments, and real estate market participants, as well as financial market professionals. With over 10 million annual unique visitors, HousingWire is the community for mortgage and housing professionals to engage and connect. Industry decision-makers rely on us to Move Markets Forward. Media Contact Annaugh MadsenPhone: (667) 260-6360Email: amadsen@ SOURCE: CMG Financial press release
